Neurocrine Biosciences News

News on Neurocrine Biosciences (Ticker: NBIX) continually updated from thousands of sources around the net.

Thursday May 17 | Drugs.com

Neurocrine Biosciences Announces Urocortin 2 Phase II Study Results...

SAN DIEGO, May 17, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure.

Comment?

Wed May 09, 2012

Seeking Alpha

Neurocrine Biosciences' CEO Presents at Deutsche Bank 37th Annual Health Care Conference

Hey, good morning everyone and thanks for attending the third and final day of the 37th Annual Deutsche Bank Health Care Conference.

Comment?

Fri May 04, 2012

Freshnews

Neurocrine Biosciences To Present At The Deutsche Bank 37th Annual Health Care Conference

SAN DIEGO, May 4, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Deutsche Bank 37th Annual Health Care Conference in Boston.

Comment?

Wed May 02, 2012

Seeking Alpha

Neurocrine Biosciences' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Good day everyone and welcome to Neurocrine Biosciences reports first quarter 2012 results.

Comment?

Freshnews

Neurocrine Biosciences Reports First Quarter 2012 Results

SAN DIEGO, May 2, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended March 31, 2012.

Comment?

Mon Apr 30, 2012

Wall St. Cheat Sheet